0001209191-21-042896.txt : 20210623
0001209191-21-042896.hdr.sgml : 20210623
20210623215007
ACCESSION NUMBER: 0001209191-21-042896
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210621
FILED AS OF DATE: 20210623
DATE AS OF CHANGE: 20210623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jenkins Annalisa
CENTRAL INDEX KEY: 0001639481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 211040441
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34715 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AgeX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821436829
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-671-8370
MAIL ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-21
0
0001708599
AgeX Therapeutics, Inc.
AGE
0001639481
Jenkins Annalisa
C/O AGEX THERAPEUTICS, INC.
1101 MARINA VILLAGE PARKWAY, SUITE 201
ALAMEDA
CA
94501
1
0
0
0
Option to Purchase Common Stock
1.48
2021-06-21
4
A
0
65000
0.00
A
2031-06-20
Common Stock
65000
65000
D
Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.
/s/Annalisa Jenkins
2021-06-23